Animas, a part of the Johnson & Johnson Family of Companies, has received CE mark approval for its Animas Vibe, a continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4 CGM technology.
The Animas Vibe insulin pump functions as a receiver for the Dexcom G4 Sensor.
The system delivers glucose information, alerts for high and low readings, and glucose trend information which enables patients to make informed decisions to help control their disease.
Unlike currently available CGM-enabled pump systems, Animas Vibe displays glucose trends with coloured arrows and lines showing where and how fast glucose levels are shifting and is waterproof.
Compatible with Diasend communications software, the device enables patients to store, review and print both CGM and insulin pump data.
Animas CMO Henry Anhalt said the CE mark approval for Animas Vibe is a milestone for their R&D program and for people living with diabetes who are seeking better ways to manage their disease.
Animas other diabetic products include the OneTouch Ping Glucose Management System and the Animas 2020 insulin pump.